Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 28 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $156K 1,200 sh | Nov 5, 2025 |
| 28 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $79K 600 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 28 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $156K 1,200 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 28 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $3.44M 596.4K sh | Nov 5, 2025 traded Nov 4, 2025 |
| 28 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $92K 700 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 28 | Wensveen MaartenEVP & Chief Technology Officer |  CMPRCIMPRESS plcOpen-market sale | SELL | $90K 1,294 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 28 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $231K 1,800 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 26 | Watanabe ToddDirector, See Remarks |  ARQTArcutis Biotherapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $284K 11.5K sh | Nov 5, 2025 traded Nov 3, 2025 |
| 26 | Carr DouglasSVP Finance & Operations |  IPSCCentury Therapeutics, Inc.Open-market sale | SELL | $171 292 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 25 | Heeson LeeEVP, Head of Incyte Intl |  INCYINCYTE CORPOpen-market sale · 10b5-1 plan | SELL | $289K 3,074 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 25 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 25 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 25 | Fang AndyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $40K 160 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 24 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.39M 596.4K sh | Nov 5, 2025 traded Nov 5, 2025 |
| 24 | Yarbrough Timothy G.EVP, Chief Financial Officer |  ZIPZIPRECRUITER, INC.Open-market sale · 10b5-1 plan | SELL | $25K 6,069 sh | Nov 5, 2025 traded Nov 5, 2025 |
| 24 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $1.26M 6,202 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 23 | Burnett PatrickSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 2,607 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 23 | Smith Michael AlexanderChief Legal Officer |  INSMINSMED IncOpen-market sale · 10b5-1 plan | SELL | $1.39M 7,619 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 23 | Shulman Douglas H.Director, President & CEO |  OMFOneMain Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $2.08M 35.0K sh | Nov 5, 2025 traded Nov 3, 2025 |
| 23 | Quigley Jill M.Director |  TERNTerns Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $441K 24.5K sh | Nov 5, 2025 traded Nov 4, 2025 |
| 23 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $177K 7,165 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 22 | Alpern Paul LVP and General Counsel |  AIPArteris, Inc.Open-market sale · 10b5-1 plan | SELL | $66K 5,000 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 21 | Singh SumitDirector, Chief Executive Officer |  CHWYChewy, Inc.Open-market sale · 10b5-1 plan | SELL | $533K 16.3K sh | Nov 5, 2025 traded Nov 3, 2025 |
| 21 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $750K 3,667 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 21 | Wensveen MaartenEVP & Chief Technology Officer | CMPRCIMPRESS plc Open-market sale | SELL | $37K 526 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 21 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $820K 3,992 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 21 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $792K 3,834 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 21 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $467K 2,305 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Burnett PatrickSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $381 15 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Smith Michael AlexanderChief Legal Officer | INSMINSMED Inc Open-market sale · 10b5-1 plan | SELL | $676K 3,636 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Stetz MattiasChief Operating Officer |  RSIRush Street Interactive, Inc.Open-market sale · 10b5-1 plan | SELL | $513K 30.0K sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Watanabe ToddDirector, See Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1,753 69 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Howse CurtisSee remarks |  SYFSynchrony FinancialOpen-market sale · 10b5-1 plan | SELL | $895K 12.1K sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Howard Justyn RussellDirector, Executive Chair, 10% Owner |  SPTSprout Social, Inc.Open-market sale · 10b5-1 plan | SELL | $204K 20.0K sh | Nov 5, 2025 traded Nov 4, 2025 |
| 20 | Rothberg Jonathan MDirector, 10% Owner |  BFLYButterfly Network, Inc.Open-market sale · 10b5-1 plan | SELL | $309K 100.5K sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Smith Michael AlexanderChief Legal Officer | INSMINSMED Inc Open-market sale · 10b5-1 plan | SELL | $600K 3,243 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Smith Michael AlexanderChief Legal Officer | INSMINSMED Inc Open-market sale · 10b5-1 plan | SELL | $783K 4,286 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Lezack AdamDirector |  BBNXBeta Bionics, Inc.Open-market sale · 10b5-1 plan | SELL | $37K 1,368 sh | Nov 5, 2025 traded Oct 31, 2025 |
| 20 | Vairavan LathaSVP Chief Financial Officer | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $2,175 88 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Smith Michael AlexanderChief Legal Officer | INSMINSMED Inc Open-market sale · 10b5-1 plan | SELL | $742K 4,032 sh | Nov 5, 2025 traded Nov 3, 2025 |